The nutritional and health properties of an oyster mushroom (Pleurotus ostreatus (Jacq. Fr) P. Kumm.)

• Autorzy: Salata A. , Lemieszek M. , Parzymies M.
• Języki publikacji: EN

Abstrakty

EN

An oyster mushroom (Pleurotus ostreatus (Jacq.) P. Kumm) is a cultivated species of mushrooms characterizing with unique culinary and medicinal properties. Its’ nutritional value comes from proteins, carbohydrates, fatty acids, vitamins and mineral nutrients present in their fruitbodies. Because of a high content of fiber (mainly chitin) and low content of fat, they are a valuable element of an atherosclerosis diet. The fruitbodies of oyster mushrooms are an important source of biologically active substances, specific polysaccharides and polyphenols, which influence a human immune system, so that it fights against cancer cells. ß-D-glucans have an advantageous effect on digestive system, lower blood cholesterol and triglycerides level, decrease the risk of ischaemic heart disease. Active substances present in the mushrooms have antioxidant, antibacterial, antiviral, antidiabetic and anti-inflammatory properties. Numerous scientific studies prove high efficiency of the therapy with the use of preparations and extracts from Pleurotus ostreatus mycelia, both in prophylaxis and cure of civilization diseases, atherosclerosis and cancer.

Słowa kluczowe

EN

mushroom cultivation; oyster mushroom; Pleurotus ostreatus; edible mushroom; nutritional property; healthy property; biologically active substance; beta-D-glucan; lovastatin

• Wydawca: -
• Czasopismo: Acta Scientiarum Polonorum. Hortorum Cultus
• Rocznik: 2018
• Tom: 17
• Numer: 2
• Opis fizyczny: p.185-197,fig.,ref.

Twórcy

autor

Salata A.

• Department of Vegetable Crops and Medicinal Plants, University of Life Sciences in Lublin, Lublin, Poland

autor

Lemieszek M.

• Department of Biomedical Science, Witold Chodzko Institute of Rural Health in Lublin, Lublin, Poland

autor

Parzymies M.

• Department of Ornamental Plants, Dendrology and Landscape Architecture, University of Life Sciences in Lublin, Lublin, Poland

Bibliografia

• Aarons, C.B., Cohen, P.A., Gower, A., Reed K.L., Leeman, S.E., Stucchi, A.F., Becker, J.M. (2007). Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Ann. Surg., 245, 176–184.
• Akyuz, M., Onganer, A.N., Erecevit, P., Kirbag, S. (2010). Antimicrobial activity of some edible mushrooms in the eastern and southeast Anatolia region of Turkey. J. Sci., 23(2), 125–130.
• Alam, N., Yoon, K.N., Lee, J.S., Cho, H.J., Shim, M.J., Lee, T.S. (2011). Dietary effect of Pleurotus eryngii on biochemical function and histology in hypercholesterolemic rats. Saudi J. Biol. Sci., 18(4), 403–409.
• Al-Hetar, M.Y., Zainal, Abidin, M.A., Sariah, M., Wong, M.Y., (2011). Antifungal activity of chitosan against Fusarium oxysporum f. sp. cubense. J. Appl. Pol. Sci., 120(4), 2434–2439.
• Anandhi, R., Annadurai, T., Anitha, T.S., Muralidharan, A.R., Najmunnisha, K., Nachiappan, V., Thomas, P.A., Geraldine, P. (2013). Antihypercholesterolemic and antioxidative effects of an extract of the oyster mushroom, Pleurotus ostreatus, and its major constituent, chrysin, in Triton WR-1339-induced hypercholesterolemic rats. J. Physiol. Biochem., 69, 313–323.
• Arora, S., Tandon S. (2015). Mushroom extracts induce human colon cancer cell (COLO-205) death by triggering the mitochondrial apoptosis pathway and Go/G1Phase cell cycle arrest. Arch. Iran. Med., 18, 284–295.
• Barros, L., Cruz, T., Baptista, P., Estevinho, L.M., Ferreira, I.C. (2008). Wild and commercial mushrooms as a source of nutrient and nutraceuticals. Food Chem. Toxicol., 46, 2742–2747.
• Bergendiova, K., Tibenska, E., Majtan, J. (2011). Pleuran (β-glucan from Pleurotus ostreatus) supplementation, cellular immune response and respiratory tract infections in athletes. Eur. J. Appl. Physiol., 111(9), 2033–2040.
• Berger, M., Gray, J.A., Roth, B.L. (2009). The expanded biology of serotonin. Ann. Rev. Med., 60, 355–366.
• Bobek, P., Galbavý, S. (2001). Effect of pleuran (ß-glucan from Pleurotus ostreatus) on the antioxidant status of the organism and on dimethylhydrazine induced precancerous lesions in rat colon. Brit. J. Biomed. Sci., 58, 164–168.
• Bobek, P., Ginter, E., Jurcovicova, M., Ozdin, L., Mekinova, D. (1991). Cholesterol lowering effect of the mushroom Pleurotus ostreatus in hereditary hypercholesterolemic rats. Ann. Nutr. Metabol., 35, 191–195.
• Bobek, P., Kuniak, L., Ozdin, L. (1993). The mushroom Pleurotus ostreatus reduces secretion and accelerates the fractional turnover rate of very-low-density lipoproteins in the rat. Ann. Nutr. Metabol., 37(3), 142–145.
• Bobovčák, M., Kuniaková, R., Gabriž, J., Majtán J. (2010). Effect of Pleuran (β-glucan from Pleurotus ostreatus) supplementation on cellular immune response after intensive exercise in elite athletes. Appl. Physiol. Nutr. Met., 35(6), 755–762.
• Brandt, C.R., Piraino, F. (2000). Mushroom antivirals. Recent Res. Dev. Antimicrob. Agents Chemother., 4, 11–16.
• Cao, X.Y., Liu, J.L., Yang, W., Hou, X., Li, Q.J. (2015). Antitumor activity of polysaccharide extracted from Pleurotus ostreatus mycelia against gastric cancer in vitro and in vivo. Mol. Med. Rep., 12, 2383–2389.
• Chen, S.Y., Ho, K.J. Hsieh, Y.J., Wang, L.T., Mau, J.L. (2012). Contents of lovastatin, γ-aminobutyric acid and ergothioneine in mushroom fruiting bodies and mycelia. LWT, Food Sci. Technol., 47, 274–278.
• Choi. D.B., Cha, W.S., Kang, S.H., Lee, B.R. (2004). Effect of Pleurotus ferulae extracts on viability of human lung cancer and cervical cancer cel line. Biotechnol. Bioprocess Eng., 9, 356–361.
• Choudhury, M.B.K., Rahman, T., Kakon, A.J., Hoque, N., Akhtaruzzaman, M., Begum, M.M., Choudhuri, M.S.K., Hossain, M.S. (2013). Effects of Pleurotus ostreatus on blood pressure and glycemic status of hyper-tensive diabetic male volunteers Bangladesh. J. Med. Biochem., 6, 5–10.
• Devi, K.S., Behera, B., Mishra, D., Maiti, T.K. (2015). Immune augmentation and Dalton’s Lymphoma tumor inhibition by glucans/glycans isolated from the mycelia and fruit body of Pleurotus ostreatus. Int. Immunopharmacol., 25, 207–217.
• Devi, K.S., Roy, B., Patra, P., Sahoo, B., Islam, S.S., Maiti, T.K. (2013). Characterization and lectin microarray of an immunomodulatory heteroglucan from Pleurotus ostreatus mycelia. Carbohydr. Polym., 94, 857–865.
• El-Fakharany, E.M., Haroun, B.M., Ng, T.B., Redwan, E.R. (2010). Oyster mushroom laccase inhibits hepatitis C virus entry into peripheral blood cells and hepatoma cells. Prot. Pept. Lett., 17, 1031–1039.
• Fu, H.Y., Shieh, D.E., Ho, C.T. (2009). Antioxidant and free radical scavenging activities of edible mushrooms. J. Food Lipids, 9, 35–43.
• Ganeshpurkar, A., Rai, G., Jain, A.P. (2010). Medicinal mushrooms: Towards a new horizon. Pharm. Rev., 4(8), 127–135.
• Gerasimenya, V.P., Efremenkova, O.V., Kamzolina, O.V., Bogush, T.A., Tolstych, I.V., Zennkova, V.A. (2002). Antimicrobial and antitoxical action of edible and medicinal mushroom Pleurotus ostreatus (Jacq,:Fr.) Kumm. Extracts. Int. J. Med. Mushrooms, 4, 127–132.
• Gapiński, M., Woźniak, W., Ziombra, M. (2001). Boczniak, technologia uprawy i przetwarzania. PWRiL, Poznań, pp., 254. Gregori, A., Svagelj, M., Pohleven, J. (2007). Cultivation techniques and medicinal properties of Pleurotus spp. Food Technol. Biotech., (45) 238–249.
• Gu, Y.H., Sivam, G. (2006). Cytotoxic effect of oyster mushroom Pleurotus ostreatus on human androgen independent prostate cancer PC-3 cells. J. Med. Food, 9, 196–204.
• Gunde-Cimerman, N., Plemenitas, A. (2001). Hyporcholesterolemic activity of the genus Pleurotus (Jacq.: Fr.) P. Kumm. (Agaricales s. l., Basidiomycetes). Int. J. Med. Mush., 3, 395–397.
• Hernandez, D., Sanchez, J.E., Yamasaki, K. (2003). A simple procedure preparing substrate for P. ostreatus cultivation. Bioresour. Technol., 90, 145–150.
• Hossain, S., Hashimoto, M., Choudhury, E.K., Alam, N., Hussain, S., Hasan, M., Choudhury, S.K., Mahmud, I. (2003). Dietary mushroom (Pleurotus ostreatus) ameliorates atherogenic lipid in hyper- cholesterolaemic rats. Clin. Exp. Pharm. Physiol., 30, 470–475.
• Hozova, B., Kuniak, L., Kelemenova, B. (2004). Application of p-D-glucans isolated from mushrooms Pleurotus ostreatus (pleuran) and Lentinus edodes (lentinan) for increasing bioactivity of yoghurts. Czech. J. Food Sci., 22(60), 204–214.
• Iwalokun, B.A., Usen, U.A., Otunba, A.A., Olukoya, D.K. (2007). Comparative phytochemical evaluation, antimicrobial and antioxidant properties of Pleurotus ostreatus. Afr. J. Biotechnol., 6, 1732–1739.
• Jayakumar, T., Thomas, P.A., Isai, M., Geraldine, P. (2010). An extract of the oyster mushroom, Pleurotus ostreatus, increases catalase gene expression and reduces protein oxidation during aging in rats. Chin. J. Integr. Med., 8, 774–780.
• Jedinak, A., Dudhgaonkar, S., Wu, Q.L., Simon, J., Sliva, D. (2011). Anti-inflammatory activity of edible oyster mushroom is mediated through the inhibition of NF-kB and AP-1 signaling. Nutr. J., 10, 52–62.
• Kalmis, E., Nuri, A., Fatih, K. (2008). Feasibility of using olive mill effluent (OME) as a wetting agent during cultivation oyster mushroom, P. ostreatus, on wheat straw. Bioresour. Technol., 99, 164–169.
• Karaman, M., Jovin, E., Malbasa, R., Matavuly, M., Popovic, M. (2010). Medicinal and edible lignicolous fungi as natural sources of antioxidative and antibacterial agents. Phytother Res., 24(10), 1473–1481.
• Keyhani, J., Keyhani, E., Arzi, L. (2007). Anti-oxidative stress enzymes in Pleurotus ostreatus. Acta Hortic., 739, 420–427.
• Khatun, K., Mahtab, H., Khanam, P.A., Sayeed, M.A., Khan, K.A. (2007). Oyster mushroom reduced blood glucose and cholesterol in diabetic subjects. Mymens. Med. J., 16, 94–99.
• Kim, J.H., Kim, S.J., Park, H.R., Choi, J.I., Ju, Y.C., Nam, K.C., Kim, S.J., Lee, S.C., (2009). The different antioxidant and anticancer activities depending on the color of oyster mushrooms. J. Med. Plants Res., 3, 1016–1020.
• Kim, M.Y., Seguin, P., Ahn, J.K., Kim, J.J., Chun, S.C., Kim, E.H., Seo, S.H., Kang, E.Y., Kim, S.L., Park, Y.J., Ro, H.M., Chung, I.M. (2008). Phenolic compound concentration and antioxidant activities of edible and medicinal mushrooms from Korea. J. Agric. Food Chem., 56(16), 7265–7270.
• Lavi, I., Friesem, D., Geresh, S., Hadar, T., Schwartz, B. (2006). An aqueous polysaccharide extract from the edible mushroom Pleurotus ostreatus induced antiproliferative and pro-apoptotic effects on HT-26 colon cancer. Cancer Lett., 224, 61–70.
• Lemieszek, M., Rzeski, W. (2012). Anticancer properties of polysaccharides isolated from fungi of the Basidiomycetes class. Contemp. Oncol., 16(4), 285–289.
• Li, Y.R., Liu, Q.H., Wang, H.X., Ng, T.B. (2008). A novel lectin with potent antitumor, mitogenic and HIV-1 reverse transcriptase inhibitory activities from the edible mushroom Pleurotus citrinopileatus. Biochim. Biophys. Acta (BBA) - General Subjects, 1780(1), 51–57.
• Lindequist, U., Niedermeyer, T.H.J., Julich, W.D. (2005). The pharmacological potential of mushrooms: Evidence based complement. Altern. Med., 2(3), 285–299.
• Maiti, S., Mallick, S.K., Bhutia, S.K., Behera, B., Mandal, M., Maiti, T.K. (2011). Antitumor effect of culinarymedicinal oyster mushroom, Pleurotus ostreatus (Jacq.: Fr.) P. Kumm., derived protein fraction on tumorbearing mice models. Int. J. Med. Mush., 13, 427–440.
• Manzi, P., Aguzzi, A., Pizzoferrato, L. (2001). Nutritional value of mushrooms widely consumed in Italy. Food Chem., 73(3), 321–325.
• Manzi, P., Marconi, S., Aguzzi, A., Pizzoferrato, L. (2004). Commercial mushrooms: nutritional quality and effect of cooking. Food Chem., 84, 201–206.
• Manzi, P., Pizzoferrato, L. (2000). Beta-glucans in edible mushrooms. Food Chem., 68(3), 315–318.
• Mattila, P., Konko, K., Euvola, M., Pihlava, J., Astola, J., Vahteristo, L. (2001). Contents of vitamins, mineral elements and some phenolic compound in cultivated mushrooms. J. Agric. Food Chem., 42, 2449–2453.
• Muszyńska, B., Komendacki, P., Kała, K., Opoka, W., Rojewski, J. (2014). L-tryptophan and its derivatives in edible mushroom species. Med. Inter. Rev., 24(103), 82–88.
• Muszyńska, B., Sułkowska-Ziaja, K., Ekiert, H. (2011a). Indole compounds in some culinary – medicinal higher Basidiomycetes from Poland. Int. J. Med. Mushrooms, 13, 449–454.
• Muszyńska, B., Sułkowska-Ziaja, K., Ekiert, H. (2011)b. Właściwości lecznicze i dietetyczne wybranych jadalnych grzybów wielkoowocnikowych. Farm. Pol., 67(8), 551–560. (In Polish)
• Muszyńska, B., Sułkowska-Ziaja, K., Ekier,t H. (2013). Phenolic acids in selected edible Basidiomycota species: Armillaria mellea, Boletus badius, Boletus edulis, Cantharellus cibarius, Lactarius deliciosus and Pleurotus ostreatus. Acta Sci. Pol., Hortorum Cultus, 12(4), 107–116.
• Ndamitso, M.M., Abulude, F.O. (2013). Nutritional assessment of some mushroom species. Electron. J. Pol. Agric. Univ., 16(4), 1–5. Avaible: www.ejpau.media. pl/volume16/issue4/art-11.htlm
• Nikolova, D., Bjelakovic, G., Gluud, L.L., Simonetti, R.G., Gluud, C. (2007). Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. J. Am. Med. Assoc., 297(8), 842–857.
• Papaspyridi, L.M, Katapodis, P., Gonou-Zagou, Z., Kapsanaki-Gotsi, E., Christakopoulos, P. (2010). Optimization of biomass production with enhanced glucan and dietary fibres content by Pleurotus ostreatus ATHUM 4438 under submerged culture. Biochem. Eng. J., 50, 131–138.
• Patel, Y., Naraian, R., Singh, V.K. (2012). Medicinal properties of Pleurotus species (Oyster mushroom): a review. Word J. Fungal Plant Biol., 3(1), 1–12.
• Piska, K., Sułkowska-Ziaja, K., Muszyńska, B. (2017). Edible mushroom Pleurotus ostreatus (Oyster mushroom) – its dietary significance and biological activity. Acta Sci. Pol., Hortorum Cultus, 16(1), 151–161.
• Ramkumar, L., Ramanathan, T., Thirunavukkarasu, P., Arivuselvan, N. (2010). Antioxidant and radical scavenging activity of nine edible mushrooms extract. Int. J. Pharmacol., 6(6), 950–953.
• Rathee, S., Rathee, D., Rathee, D., Kumar, V., Rathee P. (2012). Mushrooms as therapeutic agents. Brazilian J. Pharm., 22(2), 459–474.
• Ravi, B., Renitta, R.E., Prabha, M.L., Issac, R., Naidu, S. (2013). Evaluation of antidiabetic potential of oyster mushroom (Pleurotus ostreatus) in alloxan-induced dia-betic mice. Immunopharm. Immunotoxic., 35, 101–109.
• Refaie, F.M., Esmat, A.Y., Daba, A.S., Osman, W.M., Taha, S.M. (2010). Hepatoprotective activity of polysaccharo-peptides from Pleurotus ostreatus mycelium on thioacetamidein toxicated mice. Micol. Aplicada Int., 22, 1–13.
• Refaie, F.M., Esmat, A.Y., Daba, A.S., Taha, S.M. (2009). Characterization of polysaccharopeptides from Pleurotus ostreatus mycelium: assessment of toxicity and immunomodulation in vivo. Micol. Appl. Int., 21, 67–75.
• Reguła, J., Siwulski, M. (2007). Dried shiitake (Lentinulla edodes) and oyster (Pleurotus ostreatus) mushrooms and good source of nutrient. Acta Sci. Pol., Technol. Aliment., 6(4), 136–142.
• Santoyo, S., Ramírez-Anguiano, A.C., Aldars-García, L., Reglero, G., Soler-Rivas, C. (2012). Antiviral activities of Boletus edulis, Pleurotus ostreatus and Lentinus edodes extracts and polysaccharide fractions against Herpes simplex virus type 1. J. Food Nutr. Res., 51, 225–235.
• Sarangi, I., Ghosh, D., Bhutia, S.K., Mallick, S.K., Maiti, T.K. (2006). Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans. Int. Immunopharm., 6, 1287–1297.
• Selegean, M., Putz, M.V., Rugea, T. (2009). Effect the polysaccharide extract from the edible mushroom Pleurotus ostreatus against infectious bursal disease virus. Int. J. Mol. Sci., 10, 3616–3634.
• Shimada, Y., Yamakawa, A., Morita, T., Sugiyama, K. (2003). Effect of dietary eritadenine on the liver microsomal 1,6-desaturase activity and its mRNA in rats. Biosci. Biotechnol. Biochem., 67, 1258–1266.
• Silva, S., Martins, S., Karmali, A., Rosa, E. (2012). Production, purification and characterisation of polysaccharides from Pleurotus ostreatus with antitumour activity. J. Sci. Food Agric., 92, 1826–1832.
• Smiderle, F.R., Olsen, L.M., Carbonero, E.R., Baggio, C.H., Freitas, C.S., Marcon, R., Santos, A.R.S., Gorin, P.A.J., Iacomini, M. (2008). Anti-inflammatory and analgesic properties in a rodent model of a (1→3), (1→6)-linked ß-glucan isolated from Pleurotus pulmonarius. Eur. J. Pharmacol., 597, 86–91.
• Sobieralski, K., Siwulski, M., Lisiecka, J., Jędryczka, M., Sas-Golak, I., Frużyńska, Jóźwiak, D. (2012). Fungiderived β-glucans as a component of functional food. Acta Sci. Pol., Hortorum Cultus, 11(4), 11–128.
• Sun, Y., Liu, J. (2009). Purification, structure, and immunobiological activity of water-soluble polysaccharide from the fruiting body of Pleurotus ostreatus. Biores. Technol., 100, 983–986.
• Synytsya, A., Mickova, K., Jablonsky, I., Slukova, M., Copicova, J. (2008). Mushroom of genus Pleurotus as a source of dietary fibres and glucan for food supplements. Czech. J. Food Sci., 26, 441–446.
• Thomson, K.S., Moland, E.S. (2000). The new blastamases of Gram-negative bacteria at the dawn of the new millennium. Mic. Inf., 2, 1225–1235.
• Vargas-Sáncheza, R.D., Torrescano-Urrutiab, G.R., IbarraAriasc ,F.J., Portillo-Loeraa, J.J., Ríos-Rincóna, F.G., Sánchez-Escalante, A. (2018). Effect of dietary supplementation with Pleurotus ostreatus on growth performance and meat quality of Japanese quail. Lives. Sci., 207, 117–125.
• Venkatakrishnana, V., Shenbhagaramanb, R., Kaviyarasanb, V, Gunasundaric, D., Radhikad, K., Dandapania, R., Loganathan, L., Jagadishb, K. (2010). Antioxidant and antiproliferative effect of Pleurotus ostreatus. J. Phytol., 2, 22–28.
• Wang, J., Wang, H.W., Ng, T.B. (2007). A peptide with HIV-1 reverse transcriptase inhibitory activity from the medicinal mushroom Russula paludosa. Peptides, 28, 560–565.
• Woldegiorgis, A.Z., Abate, D., Haki, G.D., Ziegler, G.R. (2014). Antioxidant property of edible mushrooms collected from Ethiopia. Food Chem., 157, 30–36.
• Wolff, E.R.S.E., Wisbeck, M.L.L., Silveira, R.M.M., Gern, M.S.L., Furlan Pinho, S.A. (2008). Antimicrobial and antineoplasic activity of Pleurotus ostreatus. Appl. Biochem. Biotechnol., 151, 402–412.
• Wu, J.Y., Chen, C.H., Chang, W.H., Chung, K.T., Liu, Y.W., Lu, F.J. Chen, C.H. (2011). Anti-cancer effects of protein extracts from Calvatia lilacina, Pleurotus ostreatus and Volvariella volvacea. Evid. Based Compl. Alternat. Med., ID 982368, pp.
• Yang, J.H., Lin, H.C., Mau, J.L. (2002). Antioxidant properties of several commercial mushrooms. Food Chem., 77, 229–235.
• Zhang, M., Cui, S.W., Cheung, P.C.K. (2007). Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity. Trends Food Sci. Technol., 18, 4–19.
• Zusman, I., Reifen, R., Livni, O., Smirnoff, P., Gurevich, P., Sandler, B., Nyvska, A., Gal, R., Tendler, Y., Madar, Z. (1997). Role of apoptosis, proliferating cell nuclear antigen and p53 protein in chemically induced colon cancer in rats fed corncob fiber treated with the fungus Pleurotus ostreatus. Anticancer Res., 17, 2105–2113.

Identyfikatory

DOI

10.24326/asphc.2018.2.16